- Home
- EM vs IPHA Comparison
EM vs IPHA Comparison
Compare EM & IPHA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EM
- IPHA
- Stock Information
- Founded
- EM 2017
- IPHA 1999
- Country
- EM China
- IPHA France
- Employees
- EM N/A
- IPHA N/A
- Industry
- EM Other Consumer Services
- IPHA Biotechnology: Pharmaceutical Preparations
- Sector
- EM Consumer Discretionary
- IPHA Health Care
- Exchange
- EM Nasdaq
- IPHA Nasdaq
- Market Cap
- EM 191.0M
- IPHA 148.3M
- IPO Year
- EM 2021
- IPHA 2019
- Fundamental
- Price
- EM $1.07
- IPHA $1.69
- Analyst Decision
- EM Strong Buy
- IPHA Strong Buy
- Analyst Count
- EM 1
- IPHA 1
- Target Price
- EM $1.00
- IPHA $11.50
- AVG Volume (30 Days)
- EM 1.6M
- IPHA 59.0K
- Earning Date
- EM 01-21-2025
- IPHA 09-12-2024
- Dividend Yield
- EM N/A
- IPHA N/A
- EPS Growth
- EM N/A
- IPHA N/A
- EPS
- EM 0.03
- IPHA N/A
- Revenue
- EM $269,745,696.00
- IPHA $36,202,722.00
- Revenue This Year
- EM N/A
- IPHA N/A
- Revenue Next Year
- EM $6.16
- IPHA $101.65
- P/E Ratio
- EM $31.34
- IPHA N/A
- Revenue Growth
- EM N/A
- IPHA N/A
- 52 Week Low
- EM $0.43
- IPHA $1.29
- 52 Week High
- EM $1.18
- IPHA $3.51
- Technical
- Relative Strength Index (RSI)
- EM 83.22
- IPHA 42.95
- Support Level
- EM $0.68
- IPHA $1.60
- Resistance Level
- EM $1.02
- IPHA $1.87
- Average True Range (ATR)
- EM 0.05
- IPHA 0.13
- MACD
- EM 0.02
- IPHA -0.04
- Stochastic Oscillator
- EM 100.00
- IPHA 16.67
About EM Smart Share Global Limited
Smart Share Global Ltd is a consumer tech company providing mobile device charging service through an extensive online and offline network in China. It provides service through power banks, placed in POIs operated by location partners, such as entertainment venues, restaurants, shopping centers, hotels, transportation hubs, and public spaces. Through the mini-programs, users rent the power banks to carry with them when use the service and can return the power banks at any of the POIs, enabled by the expansive network and powerful technologies.
About IPHA Innate Pharma S.A. ADS
Innate Pharma SA is a clinical-stage biotechnology company. It is engaged in developing immunotherapies for cancer patients. Its approach is to harness the innate immune system through therapeutic antibodies and its ANKET (Antibody-based NK cell Engager Therapeutics) proprietary platform. The company's revenue results from payments received to research, collaboration, and licensing agreements signed with pharmaceutical companies. Its product pipeline includes lacutamab, monalizumab, IPH5201, IPH5301, IPH6101, IPH62, IPH6401 and IPH6501.